Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant imatinib in intermediate-risk gastrointestinal stromal tumor with high Genomic Grade Index
2014-005255-87Phase 3Active
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Jun 2015; status: active.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on 2014-005255-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005255-87.